Lords Mark Industries Q1 FY27: Revenue ₹3000 Cr, EBITDA margin 20%
Q1 FY27 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹280Cr
- Q1 FY26: ₹0 Cr
- −36.7% QoQ
- Net profit
- ₹32Cr
- Q1 FY26: ₹0 Cr
- −22% QoQ
- Margin
- 16%
- +3 pp QoQ
Guidance rank: #7 of 37 in Commercial Services & Supplies
See the sector's top 10 — free with your mobile number.
Lords Mark Industries Limited Q1 FY27 key numbers
- Revenue
- Renewable energy maintains a ₹3000 crore order book, providing steady revenue alongside the higher margin Medtech business.
As stated in Lords Mark Industries Limited's Q1 FY27 earnings call transcript · published 23 Sept 2026. Reported figures, not investment advice.
The short version
Lords Mark Industries expects over 20% year-on-year revenue growth, with top-line projected to exceed ₹2000 crores by FY28. Lords Mark Industries expects to cross ₹2000 crores in total revenue by FY28.
From Lords Mark Industries Limited's Q1 FY27 earnings-call transcript · updated 23 Sept 2026.
Revenue & Sales Performance
- Lords Mark Industries expects over 20% year-on-year revenue growth, with top-line projected to exceed ₹2000 crores by FY28.
- Medtech segment, including products under development like dialysis machines, Onco Diagnoscope, Onco TB Truth, Onco Spot, and sickle cell testing, is expected to contribute at least 30% to total revenue.
- The company anticipates launching these new Medtech products by Q4 FY27 or early FY28, targeting large addressable markets such as preventive healthcare and cancer diagnosis.
- Renewable energy maintains a ₹3000 crore order book, providing steady revenue alongside the higher margin Medtech business.
2 more points from Lords Mark Industries Limited's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Lords Mark Industries Limited said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Lords Mark Industries is currently not capital-intensive in manufacturing; they use OEM partners like BEL to manufacture dialysis machines to avoid heavy capex initially.
- The company plans to scale production internally and may set up their own manufacturing capex once the business stabilizes.
- Focus is on adding and developing new technologies/products acquired from government institutions rather than heavy immediate capital investment.
- Expansion plans include commercial launch of Medtech products (dialysis machine, Onco Diagnoscope, Onco TB Truth, Onco Spot) by end FY27 or early FY28, but these are primarily technology development and product launches rather than new capex projects revealed.
Top-ranked in Commercial Services & Supplies
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Lords Mark Industries Limited said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The current order book in the renewable energy and LED business is around ₹3,000 crores.
- The dialysis machine segment has an order book of over 500 machines, covering both domestic and export markets.
- The company has a decent order book to be executed in renewable energy, including rooftop solar projects under the RESCO model with UPNEDA and BREDA at a profitable tariff of ₹4.95 per unit.
- The renewable energy order book stands firm at around ₹3,000 crores as of the latest update.
2 more points from Lords Mark Industries Limited's call on order book
Create a free account to keep reading this call
Lords Mark Industries Limited — Quarterly revenue & net profit
Lords Mark Industries Limited Q1 FY27 results — key figures
| ₹ Cr | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 280 | 0 | — | 442 | -36.7% |
| Operating profit (EBITDA) | 46 | -0 | — | 59 | -22% |
| Operating margin | 16% | — | — | 13% | +3 pp |
| Profit before tax | 44 | -0 | — | 56 | -21.4% |
| Net profit (PAT) | 32 | -0 | — | 41 | -22% |
| EPS (₹) | 0.75 | -0.30 | — | 0.97 | -22.7% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹280 Cr, net profit ₹32 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Lords Mark Industries's management said in earlier quarters
Others in Commercial Services & Supplies this season
- Infollion Research Services (Q1 FY27)
Revenue from operations for FY26: ₹100.32 Crore, a 29.8% year-on-year (YoY) increase from ₹77.30 Crore in FY25 (Page 10). Key investor presentation takeaways fr
- Service Care Ltd (Q1 FY27)
EBITDA for the quarter:** ₹57.3 crore, up 27% year-on-year. Key investor presentation takeaways from Service Care Ltd's Q1 FY27 investor presentation — and how
- Credent Connect N Care (Q1 FY27)
214.16 Crores (21,416.18 lakhs), up from Rs. Key investor presentation takeaways from Credent Connect N Care Ltd's Q1 FY27 investor presentation — and how it ra
- EMA Partners (Q1 FY27)
The presentation reports consolidated operational revenue of INR 874 million for FY26, up from INR 739 million in FY25, marking an 18.2% year-on-year increase…
Potential multibaggers · Q2 FY27
Potential multibaggers in Commercial Services & Supplies
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Lords Mark Industries Limited and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Lords Mark Industries Limited Q1 FY27 results?
Lords Mark Industries expects over 20% year-on-year revenue growth, with top-line projected to exceed ₹2000 crores by FY28. Lords Mark Industries expects to cross ₹2000 crores in total revenue by FY28.
What is Lords Mark Industries Limited share price analysis?
Lords Mark Industries Limited currently shows a neutral. The stock trades at a P/E of 44.7 with a market cap of ₹3,797 Cr. Investors should review the full earnings analysis for detailed insights.
Is Lords Mark Industries Limited planning capital expenditure?
Lords Mark Industries is currently not capital-intensive in manufacturing; they use OEM partners like BEL to manufacture dialysis machines to avoid heavy capex initially.
Keep Lords Mark Industries Limited on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
